KRISTEN BLAKENEY: Open Payments
NPI 1184342164 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 14 payments from 7 companies in 2025. Trend: 2023 $644 · 2024 $62 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $79 |
| ABBVIE INC. | 4 | $78 |
| Janssen Biotech, Inc. | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Calyxo, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, IQIRVO, DUPIXENT, CVAC ASPIRATION SYSTEM, VOQUEZNA, CREON.
Industry payments across MS — which companies pay providers there.
